(19)
(11) EP 1 695 089 A1

(12)

(43) Date of publication:
30.08.2006 Bulletin 2006/35

(21) Application number: 03819144.1

(22) Date of filing: 15.12.2003
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
G01N 33/574(2006.01)
(86) International application number:
PCT/IB2003/006427
(87) International publication number:
WO 2005/062058 (07.07.2005 Gazette 2005/27)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(71) Applicant: Aurelium Biopharma Inc.
Montreal, Quebec City H2M 2N9 (CA)

(72) Inventors:
  • GEORGES, Elias
    Laval, Quebec H7M 3J7 (CA)
  • SERFASS, Lucile
    Montreal, Quebec H2T 2Z6 (CA)
  • BONNEAU, Anne-Marie
    Laval, Quebec H7M 3J7 (CA)
  • DALLAIRE, Frédéric
    Montreal, Quebec H2J 3B7 (CA)

(74) Representative: Grund, Martin et al
GRUND Intellectual Property Group Postfach 44 05 16
80754 München
80754 München (DE)

   


(54) VIMENTIN DIRECTED DIAGNOSTICS AND THERAPEUTICS FOR MULTIDRUG RESISTANT NEOPLASTIC DISEASE